FundedIQ
Biotechnology

Microba Life Sciences: Funding, Investors & Team (Sep 2026)

Microba Life Sciences Ltd. provides consumers, doctors, and researchers with gut microbiome testing services using technology for measuring the human gut microbiota. The company analyzes the microbiome to discover therapeutics, develop new diagnostic tools to understand disease through comprehensive measurement of the human gut microbiome. Microba Life Sciences was established in March 2017 by Philip Hugenholtz and Gene Tyson in Brisbane, Queensland.

www.microba.com LinkedIn Brisbane, Australia 51-100 employees
Biotechnology Genetics Health Care Life Science Wellness B2C
Total raised
$3.5M
Rounds
1
Latest
Undisclosed round
Jun 2026

Microba Life Sciences has raised $3.5M across 1 funding round on record, the most recent an undisclosed round of $3.5M announced in Jun 2026.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Microba Life Sciences Company Profile and Key Stats

Total funding raised
$3.5M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$3.5M in Jun 2026
Employees
51-100
reported band
Headquarters
Brisbane, Australia

Latest funding round on record: Jun 2026.

Microba Life Sciences Funding Rounds

Date
Round
Amount
Undisclosed round
$3.5M

Microba Life Sciences Founders and Leadership Team

Name
Role
Contact
Luke Reid
Founder
Locked

Contact details for the Microba Life Sciences team: 1 of 1 has an email address on file.

Start 14-day free trial →

Microba Life Sciences Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
1,156
$4.0M

Microba Life Sciences' latest round of $3.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Microba Life Sciences in Biotechnology and Brisbane

Companies Similar to Microba Life Sciences

AdvanCell is a company that focuses on developing innovative cancer treatments using alpha-emitting isotopes…

Series D $315M

The objective of Fluent is to seamlessly integrate humans with AI, improving interaction and communication…

Seed $2.0M

Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's…

Undisclosed round $50.0M

Algenie was founded on a simple realization: algae has the potential to save the earth, but only if it is…

Undisclosed round $990k

Paradigm Pharmaceuticals is a global biopharmaceutical company driven to discover, develop, and deliver…

Undisclosed round $10.1M

Imugene is a publicly-listed biotechnology company with operations in America and Europe,

Undisclosed round $8.6M

BiomeBank’s mission is to treat and prevent disease by restoring gut microbial ecology

Undisclosed round $10.8M

Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing…

Undisclosed round $600M

Cauldron Ferm is a technique that speeds up the production of precision fermented prototypes to commercial…

Series A $13.3M

HydGene Renewables is developing a biotechnology platform that produces on-site green hydrogen from waste…

Undisclosed round $1.4M

Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more…

Undisclosed round $320k

OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to…

Undisclosed round $19.2M

Microba Life Sciences Funding FAQs

What does Microba Life Sciences do?

Microba Life Sciences Ltd. provides consumers, doctors, and researchers with gut microbiome testing services using technology for measuring the human gut microbiota. The company analyzes the microbiome to discover therapeutics, develop new diagnostic tools to understand disease through comprehensive measurement of the human gut microbiome. Microba Life Sciences was established in March 2017 by Philip Hugenholtz and Gene Tyson in Brisbane, Queensland.

How much funding has Microba Life Sciences raised?

Microba Life Sciences has raised $3.5M across 1 round on record. The most recent is an undisclosed round of $3.5M announced in Jun 2026.

When did Microba Life Sciences last raise funding?

Microba Life Sciences' most recent funding round on record is an undisclosed round of $3.5M, announced in Jun 2026.

Who founded Microba Life Sciences?

FundedIQ lists Luke Reid (Founder) at Microba Life Sciences.

Where is Microba Life Sciences headquartered?

Microba Life Sciences is based in Brisbane, Queensland, Australia.

How many employees does Microba Life Sciences have?

Microba Life Sciences is in the 51-100 employee band.

How does Microba Life Sciences' funding compare to other Biotechnology startups?

Microba Life Sciences' latest round of $3.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Microba Life Sciences Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Microba Life Sciences is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.